The Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas, Inc.
Key Note Speaker Bios
2017

Olusola Adebisi Adeyeye

Professor Olusola Adeyeye is a Senator, Chief Whip and a member of the Independent National Electoral Commission and Constitutional Review Committees of the Senate of the Federal Republic of Nigeria. Senator Adeyeye earned a Bachelor of Science degree in Biology from the University of Ibadan and a Ph.D. from the University of Georgia. He was a Professor of Biology at Duquesne University, Pittsburgh, PA before serving in government at the local and national levels. His legislative agenda is especially focused on programs to improve Nigeria's infrastructure and human capital.

2017

Professor Maurice Iwu

Professor Maurice Iwu
President and CEO
Bioresources Development Group (BDG)
Professor Maurice Mmaduakolam Iwu is considered by many as Africa’s foremost pharmacologist and expert in tropical medicine. He is the President of Bioresources Development Group (BDG), an independent biosciences research and development organization that cultivates, processes and produces medicines and cosmetics from natural products. Prof Iwu became a Professor of Pharmacognosy at the University of Nigeria Nsukka at the age of 34 years (1984 - 1993), and a Senior Research Associate at the Division of Experimental Therapeutics of Walter Reed Army Institute of Research, Washington D.C. (1993-2003), where he conducted research on drug discovery for tropical and emerging diseases including drug-resistant malaria, leishmaniasis and Ebola virus. He is the founder and Chairman of Bioresources Development and Conservation Programme (BDCP) in Nigeria and Cameroon, Bioresources Institute of Nigeria (BION) and the International Centre for Ethnomedicine and Drug Development (InterCEDD), He was the Vice President, Research and Development at Tom’s of Maine (a personal care manufacturing company in Maine, U.S. A.). He is the Chairman of the Board of Directors of InterCEDD Health Products, a dietary supplements manufacturing and marketing company, and Nature’s Emporium a chain of health and wellness outlets in major cities in Nigeria.
2017

Dr. Oluyinka Olutoye

Dr. Oluyinka Olutoye
MD, Ph.D
Professor of Surgery, Pediatrics, Obstetrics and Gynecology
Baylor College of Medicine
Dr. Oluyinka O. Olutoye has specialized clinical expertise in fetal and neonatal surgery with specific interest in congenital diaphragmatic hernia and complex wounds. Dr. Olutoye is the 2016 Co-president of the International Fetal Medicine and Surgery Society, a Fellow of the Surgical Section of the American Academy of Pediatrics and American College of Surgeons, and a Fellow of the West African College of Surgeons. He is certified by the American Board of Surgery both in general surgery and pediatric surgery.
2017

Professor Isa Odidi

Professor Isa Odidi
Founder, Chairman and CEO
IntelliPharmaCeutics, Canada
Professor Isa Odidi is a founder and one of the principals of IntelliPharmaCeutics, and serves as Chairman of the Board, Chief Executive Officer, Co-Chief Scientific Officer and Chair of Scientific Advisory Board. In the pharmaceutical industry, Professor Odidi is highly regarded for his entrepreneurial acumen, something rare for a scientist. Professor Odidi is also a highly respected innovator and inventor with a long history of success. His work has been cited in textbooks and he has published over a hundred scientific and medical papers, articles and textbooks.
2016

Prof. Isaac Adewole

Professor Isaac Folorunso Adewole is from Osun State.

He attended Ilesha Grammar School and proceeded to the University of Ibadan where he graduated with a Bachelors Degree in Medicine in 1978.

He became a Professor of Medicine from the College of Medicine, University of Ibadan in 1997, and was appointed Provost, College of Medicine in 2002.

Professor Adewole has worked at the University College Hospital (UCH) Ibadan in different capacities. Until his nomination as a Minister, he was the Vice Chancellor of the University of Ibadan, a position he has occupied since 2010.He is similarly an adjunct professor, North-Western University, Chicago, Illinois, USA – a position he has held since 2010.

Professor Adewole is a recipient of several scholarships, fellowships and awards.

2015

Pharm. Lekan Asuni

Lekan Asuni, General Manager/Managing Director, GSK Pharmaceutical Nigeria, currently serves as a non-executive Director on the board of GSK Consumer Nigeria Plc.  He has vast experience in strategic leadership, marketing management (cutting across different categories), sales management, business development, project management, intellectual property protection and public health. In addition, he has considerable diverse senior leadership experience and distinguished himself with a proven track record of delivering significant business results and growth in the pharmaceutical industry.

He demonstrates sterling leadership qualities, high learning agility, emotional intelligence, humility and a drive for success. Lekan is passionate about developing people and has, over time, developed a robust talent pipeline for his entity in the organisation.

As part of the achievements to his credit, he doubled the size of the business in West Africa with a CAGR (compound annual growth rate) of near 30% between 2008 and 2013. In 2011/2012; he participated as a member of the first cohort of Leading Business Leadership Development Programme where his competitive edge assignment was ranked among the top three. Prior to this, he was a key talent and participant at the President’s exchange program in 2005 and has had market immersion in South Africa, India, and the United Kingdom

He is an active member of some professional associations where he served and earned awards in various capacities.  He is a Fellow of the Pharmaceutical Society of Nigeria (FPSN); a Fellow of the Institute of Logistics Management of Nigeria; a Fellow of the Academy of Pharmacy of Nigeria and a Fellow of the National Institute of Marketing of Nigeria.  He is also a Member of the Corporate Governance Society, Nigeria; a Member Nigerian Institute of Management; a Member of National Competitiveness Council of Nigeria; a Member of the Private Sector Health Alliance of Nigeria.  He is currently the President of Nigeria Association of Representatives’ of Overseas Pharmaceutical Manufacturers (NIROPHARM).

Lekan holds a Bachelor of Pharmacy degree from Obafemi Awolowo University, Ile-Ife, Nigeria and a Master of Business Administration (MBA). He is an Alumnus of Ashridge Business School, UK and has also attended several general management and function-specific workshops and courses in Nigeria and internationally

His hobbies include listening to music, dancing and jogging. Lekan is happily married and blessed with lovely children

2015

Benjamin Nnamdi Ohiaeri, MD, Founder and Chief Medical Director

Dr. Benjamin Nnamdi Ohiaeri is the Founder and Chief Medical Director of First Consultants Medical Center Limited. He also serves as the majority shareholder of EarthCare Nigeria Limited and the chairman of the Abuja International Diagnostic Center.

In 1980, Dr. Ohiaeri made his mark in the Nigerian healthcare sector while working as an outstanding medical consultant at the Lagos Island Maternity Hospital.  Dr. Ohiaeri’s vision of excellent, patient-centered medical care in Nigeria was realized when he established First Consultants Medical Center Limited, Lagos in 1982. Dr. Ohiaeri served as the obstetrician and gynecologist to the families of two Nigerian presidents. At the invitation of the Federal government, Dr. Ohiaeri designed and influenced the creation of the National Hospital for Women and Children, Abuja. His dedication to excellence in maternal care has influenced his other business interests. EarthCare Nigeria Limited, the largest compost plant in West Africa, converting municipal solid waste to organic fertilizer, commits 30% of its Grade A organic fertilizer to women farmers, while creating jobs for unemployed youth and cleaning the environment. Dr. Ohiaeri has been conferred with much recognition for his commitment to healthcare, environmental sustainability, and education.

Dr. Ohiaeri earned his MBBS from the University of Lagos and completed his externship at the University of Rochester, School of Medicine. Dr. Ohiaeri did his residency training in Obstetrics and Gynecology at St. Elizabeth Medical Center, Ohio (an affiliate of Case Western Reserve) and took many courses at institutions across the US including Harvard Medical School. Dr. Ohiaeri is a Diplomate of the American Board of Obstetrics and Gynecology. Dr. Ohiaeri is a keen sportsman and enjoys playing the alto saxophone.

2014

Mazi Sam I. Ohuabunwa, MON FPSN FPC

Mazi Sam I. Ohuabunwa (MON) is the President/Chief Executive Officer, Neimeth International Pharmaceuticals Plc., Nigeria; Chairman, Worldwide Health Care Ltd., Red Star Communications Ltd., Masta Services   Company Ltd., Multimesh Communications Ltd., Arochukwu MicroFinance Bank Ltd., Fairway Insurance Brokers Ltd.,   Innochris and Life Drug World Ltd., Nigeria.  He obtained his B. Pharm from University of Ife, Nigeria and completed his postgraduate studies at Columbia University,   New York, USA and Lagos Business School, Nigeria.  Mazi Ohuabunwa is a Fellow of Pharmaceutical Society of Nigeria (FPSN), West African Postgraduate College of   Pharmacists (FPC Pharm), Nigerian Institute of Management (FNIM), National Institute of Marketing of Nigeria (FNIMN),   Nigerian Institute of Public Relations (FNIPR), Institute of Management Consultants (FIMC), and Institute of Quality   Assurance of Nigeria (FIQAN).  As a prolific writer, he has published numerous books with titles including Taking the Bull the Horn; Service to My People;   Economic Empowerment for God’s People – The 21st Century Challenge; Transforming Ideas into Reality; Achieving Results   through People; Preventing Business Failures; Wealth Creation: Migrating from the Informal to the Formal Sector; and Nigeria @ 50: Time for the Evolution of a New Nation.

2013

Osagie Imasogie Senior Managing Partner Phoenix IP Ventures LLC

Professor Imasogie is the I Grant Irey Adjunct Professor at the University of Pennsylvania Law School where he teaches a seminar on “Intellectual Property and National Economic Value Creation”. In addition, Osagie is a member of the Board of Overseers of the University of Pennsylvania Law School.

Osagie is also the 2008 recipient of the Penn Law School Alumni Award of Merit. In addition, Osagie is a member of the Board of Trustees of the University of Pennsylvania.

Osagie has over 30 years of experience in the fields of law, finance, business management, healthcare and the pharmaceutical industry.

Prior to co-founding Phoenix IP Ventures, an IP based Merchant Bank, Osagie conceptualized and established GlaxoSmithKline Ventures and was its founding VP. Osagie led GSK Ventures in investing over 30 GSK R&D non-progressed assets into existing companies and/or as the basis of starting new companies. Prior to this role within GSK, Osagie was a VP at SmithKline Beecham, was the Founding SVP for Business Development and General Counsel at Endo Pharmaceuticals Inc., a multi-billion dollar publicly traded specialist pharmaceutical company, served as a DuPont Merck VP of International Sales and Marketing and General Counsel to DuPont Merck’s International, Manufacturing and Generic Drug Divisions.

Osagie has also been a Price Waterhouse Corporate Finance Partner and the Partner-in- Charge for PW Corporate Finance activities for West Africa as well as a practicing attorney with a leading US Law Firm in the fields of corporate, corporate finance, taxation and intellectual property law. Osagie is Chairman of Iroko Pharmaceuticals and iCeutica Inc. and the former Chairman, CEO and founder of Ception Therapeutics and a board member of several pharmaceutical, biotech and financial companies. Osagie holds post-graduate degrees from the London School of Economics and the University of Pennsylvania Law School.”

2012

John Agwunobi, MD, MBA, MPH

Dr. John O. Agwunobi, Senior Vice President and President of Professional Services for Wal- Mart Inc. Dr. Agwunobi oversees the company’s health and wellness business unit, including pharmacies, vision centers, and health care clinics. He joined the company in September 2007.
Prior to joining Wal-Mart, he was the Assistant Secretary for Health for the U.S. Department of Health and Human Services and an Admiral in the U.S. Public Health Service Commissioned Corps. As Assistant Secretary for Health, Dr. Agwunobi’s served as the Secretary's primary advisor on matters involving the nation's public health. His responsibilities included disease prevention, health promotion, women’s and minority health, the reduction of health disparities, fight against HIV/AIDS, pandemic influenza planning, and vaccine preventable diseases. He was actively involved in the push for improvements in research and enhanced access to quality health care. Before becoming the Assistant Secretary for Health, Dr. Agwunobi served as Florida’s Secretary of Health. In that role, he confronted many public health challenges, including leading the state’s public health and medical response to the unprecedented four major hurricanes that struck Florida in 2004. Dr. Agwunobi led the state’s response to the nation’s first-ever intentional anthrax attack of 2001. He subsequently guided Florida’s nationally recognized efforts to protect the state against bioterrorism. As Secretary, Dr. Agwunobi led the call for a healthier Florida, advocating for improved nutrition and exercise in an effort to address the state's epidemic of overweight and obesity. His Department's many successes included responses to West Nile, SARS, and numerous other infectious disease outbreaks; efforts to decrease the state's infant mortality rate; lowering tobacco use among young Floridians; addressing racial and ethnic health disparities; and improving overall access to medical and dental care. As a pediatrician, Dr. Agwunobi dedicated himself to working with underserved populations.


Dr. Agwunobi has been the recipient of numerous honors and awards, including Public Administrator of the Year, APHA Public Health Hero Citation, and Honorary Doctorate of Humane Letters.
2011

ShaAvhrée Buckman, M.D., Ph.D., FAAP

Dr. ShaAvhrée Buckman is the Director of the Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration.  OTS is comprised of the Office of Biostatistics, Office of Clinical Pharmacology, and provides oversight to CDER research involving human subjects as well as CDER regulatory science research.  OTS is responsible for providing coordination for Critical Path initiatives across CDER in partnership with individual CDER offices. Prior to serving as Director of OTS, Dr. Buckman served as Deputy Director for OTS and as medical team leader in the Division of Pediatric Drug Development, Office of Counter Terrorism and Pediatric Drug Development, CDER. Dr. Buckman received her MD and PhD degrees with an emphasis on molecular cell biology from Washington University School of Medicine.  Dr. Buckman completed Pediatric specialty training at Baylor College of Medicine. She is a board-certified Pediatrician, who has had a career-long interest in medications for children.

2010

Linus Igwemezie, Ph.D.

Executive Vice President and Head, Malaria Initiative, responsible for developing and executing strategies to maintain Novartis leadership in malaria control and elimination. Previously, Vice President, New Products and Portfolio Strategy in Novartis Oncology, leading the commercial development of new drug candidates, and evaluation of in-licensing and M&A opportunities. Also served as Executive Director, New Products and Disease Strategy. Before Joining Novartis Oncology in 2001, was Director, Global Marketing and Director, Regulatory Affairs at Bristol-Myers Squibb; Research Scientist at Merck.  BS University of Ife, Nigeria; PhD University of British Columbia, Vancouver; and MBA Wharton School, University of Pennsylvania.

2009

Ngozi Okonjo-Iweala, Ph.D.

Dr. Ngozi Okonjo-Iweala is currently a Managing Director of the World Bank. She was a Distinguished Visiting Fellow at Brookings Institution, Washington, D.C from September 2006 to November 2007. Prior to that she was Finance Minister of Nigeria for three years and briefly Minister of Foreign Affairs. As Minister of Finance, she spearheaded negotiations with the Paris Club of Creditors that led to the cancellation of US$18 billion or 60 percent of Nigeria’s external debt. Dr. Okonjo-Iweala is a member or chair of numerous boards and advisory groups, including ONE Campaign, the World Resources Institute, the Rockefeller Foundation, the African Institutes of Science and Technology as well as the Center for Global Development (CGD). She has served on the advisory board of the Clinton Global Initiative and as adviser to several international investment groups working in emerging markets. She has lectured extensively all over the world on development issues especially on Africa. Dr. Okonjo-Iweala was the founder of the first ever indigenous opinion research organization in Nigeria (NOI-Gallup Polls). She was co-founder of the Makeda Fund, a US$50 million private equity fund that invests in women-owned small and medium enterprises in Africa. She founded the Center for the Study of Economies of Africa (C-SEA), a development research think-tank based in Abuja, Nigeria. She was recently named a member of the Danish-Government led Commission on Africa and a member of the World Economic Forum Global Leadership Council on Transparency and Corruption. She is also a member of the renowned Commission on World Growth led by Nobel Prize winner, Professor Michael Spence.

Dr. Okonjo-Iweala was educated at Harvard University and has a PhD in Regional Economics and Development from the Massachusetts Institute of Technology. She is the recipient of numerous awards, including Honorary Doctorates from Trinity College, Dublin Brown University and Amherst University, USA, among others. She is the recipient of Time Magazine’s European Hero of the Year Award, 2004, for her work on economic reform in Nigeria, Euromoney Magazine Global Finance Minister of the year, 2005, Financial Times/The Banker African Finance Minister of the year 2005, This Day (Nigeria’s premier newspaper) Minister of the Year award 2004 and 2005. In 2006, she was named by Forbes Magazine as one of 100 most powerful women in the world. She has been profiled in the Conde Nast International Business Intelligence Magazine Portfolio as one of 73 “Brilliant” business influencers in the world.

2008

Mazi Sam I. Ohuabunwa

Mazi Sam I. Ohuabunwa (MON) is the President/Chief Executive Officer, Neimeth International Pharmaceuticals Plc., Nigeria; Chairman, Worldwide Health Care Ltd., Red Star Communications Ltd., Masta Services Company Ltd., Multimesh Communications Ltd., Arochukwu MicroFinance Bank Ltd., Fairway Insurance Brokers Ltd., Innochris and Life Drug World Ltd., Nigeria. He obtained his B. Pharm from University of Ife, Nigeria and completed his postgraduate studies at Columbia University, New York, USA and Lagos Business School, Nigeria. Mazi Ohuabunwa is a Fellow of Pharmaceutical Society of Nigeria (FPSN), West African Postgraduate College of Pharmacists (FPC Pharm), Nigerian Institute of Management (FNIM), National Institute of Marketing of Nigeria (FNIMN), Nigerian Institute of Public Relations (FNIPR), Institute of Management Consultants (FIMC), and Institute of Quality Assurance of Nigeria (FIQAN). As a prolific writer, he has published numerous books with titles including Taking the Bull the Horn; Service to My People; Economic Empowerment for God’s People – The 21st Century Challenge; Transforming Ideas into Reality; Achieving Results through People; Preventing Business Failures; Wealth Creation: Migrating from the Informal to the Formal Sector; and Nigeria @ 50: Time for the Evolution of a New Nation.

2007

Dora Nkem Akunyili, Ph.D.

Prof. Dora Nkem Akunyili (OFR), the Director General of National Agency for Food and Drug Administration and Control (NAFDAC), is an internationally renowned Pharmacist, Pharmacologist, Erudite Scholar, Seasoned Administrator, and a visionary leader. Prior to her present appointment, she was a Senior Lecturer and Consultant Pharmacologist in the College of Medicine, University of Nigeria Nsukka (U.N.N.), Enugu Campus. Prof. Akunyili obtained her B.Pharm (Hons) in 1978 and P.hD in 1985, both at University of Nigeria Nsukka (U.N.N.). Prof. Akunyili won the best student award in the school of Pharmacy in her very first year in the school and the Vice Chancellor’s Postgraduate and Research Leadership prize in Faculty of Pharmaceutical Sciences for 1984/85 and 1985/86 academic Sessions. Prof. Akunyili started her working career as a Hospital Pharmacist in the University of Nigeria Teaching Hospital (U.N.T.H) Enugu in 1978. In 1981, she ventured into Academics as a Graduate Assistant (Research Fellow) in the Faculty of Pharmaceutical Sciences, U.N.N. In the University system, she made a steady progress from lecturer I in 1986 until she was made Senior Lecturer in 1990.

She transferred to College of Medicine, U.N.N. in 1992 and became a Consultant Pharmacologist in 1996. She was promoted to the rank of a Professor in October, 2000 by the same University. From 1992 to 1994, Prof. Akunyili served as a member of Anambra State’s Hospitals Management Board and State Advisory Council for Women Commission, and was appointed Supervisory Councilor for Agriculture in Anaocha Local Government of Anambra State, Nigeria from 1994 – 1996 Prof. Dora Akunyili was appointed Zonal Secretary of Petroleum Special Trust Fund (P.T.F.), coordinating all projects in the five South Eastern States of Nigeria from 1996 - 2000.

As a Scientist and a Scholar, she has presented 20 papers in various Local and International Scientific Conferences, published two books and 33 Journal Articles. She also supervised PhD and Masters candidates, and is currently supervising six Postgraduate students in the College of Medicine U.N.N.